Physician profile
Sadia Khan
NPI 1205134665
$12,056.62
in general payments reported to CMS, 2019-2025
13 companies · $1,074 in 2025
The $1,074 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $745 · 2020: $2,500 · 2021: $73.12 · 2022: $4,627 · 2023: $2,343 · 2024: $694 · 2025: $1,074.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,174 · Travel and Lodging: $937.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,173.99 |
| Travel and Lodging | $937.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endomagnetics LTD | $5,831.87 | 2019-2025 | Magtrace, Magseed, Sentimag |
| Icad, INC | $2,500.00 | 2020 | |
| Axogen | $1,455.96 | 2023 | Axoguard Nerve Protector, Axoguard Nerve Connector, Avance Nerve Graft |
| Vector Surgical, LLC | $752.28 | 2019-2025 | |
| Hologic Sales and Service, LLC | $444.10 | 2025 | Magtrace, Magseed |
| Sirius Medical Systems | $336.31 | 2023-2024 | Pintuition |
| Musculoskeletal Transplant Foundation INC. | $240.70 | 2025 | |
| Hologic INC | $153.39 | 2019 | |
| Leica Microsystems INC. | $114.44 | 2019-2022 | |
| Isono Health, INC. | $88.76 | 2025 | Atusa |
| Abbvie INC. | $82.20 | 2021-2024 | |
| Celgene Corporation | $40.99 | 2023 | Reblozyl |
| Boston Scientific Corporation | $15.62 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sadia Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.